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Abstract 
Personalized medicine has become a goal of genomics and of health policy makers. This article reviews two recent books that are highly critical 
of this approach, finding their arguments very thoughtful and important.  According to Stengers, biology’s rush to become a science of genome 
sequences has made it part of the “speculative economy of promise.” Reardon claims that the postgenomic condition is the attempt to find mean-
ing in all the troves of data that have been generated. The current paper attempts to extend these arguments by showing that scientific alterna-
tives such as ecological developmental biology and the tissue organization field theory of cancer provide evidence demonstrating that genomic 
data alone is not sufficient to explain the origins of common disease. What does need to be explained is the intransience of medical scientists to 
recognize other explanatory models beside the “-omics” approaches based on computational algorithms. To this end, various notions of com-
modity and religious fetishism are used. This is not to say that there is no place for Big Data and genomics. Rather, these methodologies should 
have a definite place among others. These books suggest that Big Data genomics is like the cancer it is supposed to conquer. It has expanded 
unregulated and threatens to kill the body in which it arose. 
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1. Introduction
We scientists have always liked Plato’s allegory of the 
cave. We are the draggers, after all, who bring the un-
willing citizens of the world out of the cave and dispel 
their illusions. But what if, in some Matrix-like man-
ner, this world of enlightenment were, itself, only a 
better-constructed cave? How would we react to some-
one who was trying to drag us out of it, saying that 
there was a richer, “truer,” reality? Would we, too, go 
kicking and screaming? Two thought-provoking and 
intelligently argued books, Jenny Reardon’s The Post-
genomic Condition: Ethics, Justice, and Knowledge after the 
Genome and Isabelle Stengers’ Another Science is Possible: 
A Manifesto for Slow Science, attempt to expose the na-
ture-deprived, commercially driven, ethos of our bi-
otechnological world, demand that we see its incon-
venient truths, and that some of us then return to try 
freeing the others.
In The Postgenomic Condition, biologist-turned-soci-
ologist Jenny Reardon sees genomic medicine as a sal-
vage-attempt to wrest meaning from the various human 
genome projects undertaken throughout the world. 
She takes us through the history of DNA sequenc-
ing projects as well as through the narratives spun by 
these genomics communities. Their narratives portray 
genomics as producing a more just world, a more open 
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society, and a community free from disease1. However, 
Reardon insists that the “-omics” narratives end up in 
one and the same basin, econ-omics. Genome collections 
become potential treasure-troves of data for the infor-
mation economy, and a nation’s or a region’s genomic 
repository could become a natural resource at a time 
when other natural resources are dwindling. The trou-
ble for the genome projects, she insists, is that there is no 
obvious meaning in any of these collections. The hope 
that genome-wide association studies (GWAS) would 
quickly identify common allelic variants that produced 
or made one susceptible to common non-infectious dis-
eases (e.g., diabetes, cancers, cardiovascular disease) or 
various behavioral conditions has not been fulfilled (and 
is unlikely to be so; Weiss and Terwilliger, 2000; Gilbert 
and Epel, 2015; Weiss 2017; Torkamani et al 2018). 
The Postgenomic Condition looks at the failure to find 
meaning in the genome, a failure so profound that Craig 
Ventor, one of the major actors in sequencing of human 
genomes, claimed that from all the genomes sequenced, 
we still can’t even tell what color our eyes would be, 
let alone whether or not we would have cancer (Ven-
tor, cited in Reardon, 2017). Reardon also looks at the 
moral failure of the funding agencies to recognize that 
in funding the sequencing projects, one is not funding 
other projects that may address more immediate health 
needs. Using Hannah Arendt’s notions of active think-
ing and the ethics of attention, Reardon, the director of 
The Science and Justice Research Center at the Univer-
sity of California, Santa Cruz, calls for a re-evaluation 
of who benefits from genomics. When a University of 
California medical school is building a genomics center 
while closing a clinic for families with low incomes, she 
finds that something is definitely wrong. Similarly, she 
feels the health needs of Amerindian tribes better served 
by providing clinics, physicians, and counseling than by 
genome projects. Indeed, many tribal leaders felt that 
the scientists of the HGDP were insensitive to the Indian 
notions of body sacredness and to tribal health needs 
(Dukepoo 1998a,b; IPCB 2000).
Just as Reardon’s book follows Arendt’s call to “think 
what we are doing”, Isabelle Stengers’ (2018) Another Sci-
ence is Possible, calls for a mindful science, a science where 
thought is given to cultural matters. Using the model of 
“slow food,” where care is taken in the acquisition and 
preparation of what we eat, Stengers calls for a “slow 
science” where “matters of concern” matter as much 
1 They still do. Reardon’s book gives us an interesting context into which 
to place the rhetoric of biotech ameliorism, such as Bill Gate’s (2018) 
article in Foreign Affairs.
as “matters of fact”. Modern scientists, she believes, are 
caught-up in showing that they have “the right stuff,” 
the abilities to thrive in hard times, and to speed head-
long into their endeavors without thinking of peripheral 
issues such as who benefits from their findings or what 
these findings might do to change or abrogate social re-
lationships. Her experience in the European debate con-
cerning genetically modified vegetables showed her the 
difference between laboratory scientists and field scien-
tists. The former criticized the latter as being sentimental 
women, i.e., not having the “right stuff.” 
Like Reardon, Stengers finds the genome projects 
to be exercises in capitalism more than in science or 
medicine. Stengers tells us that what constitutes a valid 
research program has become an opinion backed by 
financial resources. (P. 31). Science, she says, has been 
captured by industry, and as such, has been redefined 
as part of the “knowledge economy.” Worse, she con-
tinues (p. 54), biological science, now rebranded as bio-
technology, has become part of a “speculative economy 
of promise.” Like derivative stocks, one isn’t buying a 
product, but the perception that the promise of a prod-
uct will be fulfilled. 
Stengers confirms and extends Reardon’s invocation 
of Arendt by citing Virginia Wolff’s “Let us never stop 
thinking ‘what is this ‘’civilization’’ in which we find 
ourselves?’”. And chief among her thoughts is the re-
definition of excellence in science. When “excellence” is 
defined by internal professional parameters, and not by 
the consensual standards of the community, then sci-
ence, as well as the rest of the academic world, will be 
destroyed by that pursuit of excellence. It would be a 
difficult, and probably a self-defeating, process to make 
science obey any community standard (especially when 
hyper-capitalism has become that standard). It would 
be better (see Section 2) to imbue scientists with critical 
and social sensibilities. 
Both Reardon’s and Stengers’ books see genomics 
as the end of biology. Reardon sees genomics as a field 
where algorithms replace hypotheses, and practitioners 
claim that their lack of biological knowledge gives them 
more objectivity. But objectivity, she notes, is lost in the 
notion of “curatorship,” where DNA connoisseurs de-
termine which sequences are more informative (liter-
ally) than others. Rather than preserve organisms, the 
wardens preserve sequences. Speed, automation, and 
computers are now the engine of biology, because ge-
nomes, rather than organisms, are seen to have agency. 
It is Richard Dawkin’s view of the world writ large in 
Jacques Ellul’s “Technique”. 
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Reardon’s major question (p. 27) thus becomes, 
“How can we know and act ethically in a world where 
life becomes information, information becomes capital, 
and capital is equated with freedom?”. Lest one think 
that this is a fantasy, check out the website of the United 
States’ newest genome initiative, “All of Us” (NIH 2018):
Starting this spring, Americans across the country 
will be invited to contribute to a massive new pool of 
genomic information being assembled by the govern-
ment, a project that represents the most ambitious ef-
fort yet to capitalize on the promising new frontier of 
gene-based medicine. 
Their use of the word “capitalize” is telling and rings 
true2, for the promise of the information economy is that 
data is wealth. If the goal of science is public information 
(i.e., ”publications”), and the goal of technology is pri-
vate information (i.e. “patents”), then which form wins 
in the fused entity called “technoscience”? The answer, 
Reardon claims, is: Patents and the private ownership of 
information. Reardon takes us on the journey from the 
“opening” of DNA sequences to the public and the partic-
ipatory democracy that was supposed to end the feudal 
patriarchy of big science, through the business models of 
ABA and Illumina sequencers, to the era where corpora-
tions use identity politics to recruit paying customers to 
enlarge their databases. As has also been documented by 
Stevens (2013), this is a mode of science that is not that of 
biology, but one that (p. 200) “might suit computers and 
the computer scientists who program them.”
Stengers claims that scientists need to reclaim their 
science from industry. Actually, she claims more than 
that. Scientists will have to reclaim the art of dealing with 
and learning from that which is messy. Like Haraway’s 
“staying with the trouble,” scientists will have to under-
stand that the scientific environment has become toxic, 
not only making the world sick, but making the scientists, 
themselves, despondent and depressed, divorced from 
that which they have loved. If science is an army fighting 
ignorance and disease (as in the “war on cancer”), then 
it has to acknowledge the damage inflicted not only on 
its enemy, but also on its soldiers and on the surround-
ing countryside. Perhaps seeing the military metaphor 
from a Belgian perspective, Stengers would have scien-
tists on a journey (where the countryside is appreciated 
2 This paragraph containing “capitalize” was removed from the 
first page of the website once the program was started. However, it 
can still be found in other areas of the site (https://allofus.nih.gov/
about/scientific-opportunities) as of April 4, 2018. The original 
wording of the press release can be found in the Washington Post 
(Cunningham 2018).
as part of the goal) rather than a march. Armies, she 
says, are mechanized, not civilized, and Stengers would 
want the soldiers of science to demobilize and civilize 
themselves once more, learning from others. Civiliza-
tion, she notes, involves reciprocity, even learning that 
there are some instances where opinions matter, and 
that often, a scientific research program (no matter how 
much excellence there be in its papers) can be merely a 
well-funded opinion. 
And what will happen to other research programs, 
if organisms are seen as mere epiphenomena of their 
genomic sequences and its products? Indeed, Reardon 
asks (p. 200), “what will become of the vast stores of 
biological knowledge and practices for knowing life 
crafted over the centuries—taxonomy, descriptive de-
velopmental biology, for example—that do not fit easily 
into this big data approach?” 
The answer to this question is as easy as it is tragic. 
The sciences will be redefined to fit the methodology. 
This happened when genetics redefined evolution as 
changes in allele frequency and redefined develop-
ment in terms of gene expression. It happened when 
taxonomy was redefined by cladistics. The redefinition 
of biology to make it more mathematical has been an 
ongoing project of those who believe that a discipline is 
scientific only to the extent that mathematics presides 
(Gilbert, 2018), and genomics is the newest approach to 
set aside as secondary anything that is physical. Biolo-
gy would become a science of algorithmic abstractions, 
not of cells, organs, or organisms. Ask any biologist 
who works on organisms about the pressing need to 
“go genomic” when writing grant applications. If one 
wishes to survive, one redefines one’s work. Medicine, 
moreover, would become a means of applying those 
algorithms in a healthcare system optimistically called 
“personalized medicine.”
2. Alternatives 
Those of us with a few miles on the odometer may 
recall anthropologist Horace Miner’s remarkable 1956 
study of “body ritual among the Nacirema.”Indeed, 
this paper is still given to students in many cultural an-
thropology courses in order to illustrate the extremes of 
“magical beliefs and practices.” Members of this North 
American tribe divided their time between laboring 
in its highly developed market economy and perform-
ing the ritual activities needed for the maintenance 
of their bodies, which they believed to be ugly and 
disease-prone. Each of the native’s houses contained 
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at least one shrine for the ritual activities of cleansing and 
beautifying the body, and the worth of a home was of-
ten described in the number of such shrines. Without the 
magical potions used in these rooms, the Nacirema be-
lieved they would be deformed and severely debilitated. 
Of course, this tribe was the dominant white culture 
of the USA (“Nacirema” spelled backwards). But how-
ever ritualistic its hygienic practices might be, its med-
ical system prided itself in being based on empirical 
and experimental science. Since the Flexner Report of 
1910, Western (and especially, American) medicine has 
claimed to distinguish itself from the ideologically or 
theologically based medical practices of other cultures 
by our regard for scientific evidence. 
Until recently. It now appears that Western medi-
cine is turning its back on science and is putting its faith 
and its funding in a cultural ideology based in genom-
ics and the genetic conception of human individuality. 
The books by Stengers and Reardon provide provoca-
tive and thoughtful evidence for genomics as a faith-
based medical belief and a basis for a biology lacking 
physicality or carnality. But the argument must also be 
made that there are social and scientific alternatives to 
the genomic reorganization of biology and medicine. 
First of all, there is a very successful alternative to 
science as a commercialized march to “progress.” This 
is the approach taken by the liberal arts college, a model 
that takes pride in seeing science in context and in inte-
grating science with the humanities and social sciences. 
These schools have been remarkably successful in gen-
erating important scientists. Seven of the ten schools 
whose graduates earn the most PhDs are liberal arts 
schools. One such college, Swarthmore College (whose 
logo is a scroll, a telescope, a chemical retort, and a mi-
croscope atop a book), is fourth in the number of No-
bel Prize winners and members of the U. S. National 
Academy of Sciences per undergraduate student (Hsu 
and Wai 2015; Clynes 2016). In a very important way, 
the American liberal arts college is attempting to teach 
and perform the mindful science that Stengers so force-
fully recommends, and other institutions, especially 
the honors colleges and interdisciplinary programs at 
many universities, are using this model. Root-Bernstein 
(1989) sees this approach as being critical for American 
science, and he documents that most of the scientists 
who make major discoveries have been those who were 
trained (or-self-trained) in the arts and humanities. The 
liberal arts approach allows opinions, doubt, and social 
context to be spoken aloud in science.
One scientific alternative to the high-tech genomics 
freeway is the recently formulated science of ecological 
developmental biology (Gilbert and Epel, 2015; Sultan, 
2015). This is a science where organisms and environ-
ments possess agency, and the genome is both passive 
and active. It integrates the work of C. H. Waddington 
(environmental agency), Richard Lewontin (develop-
mental plasticity), and Lynn Margulis (intra-organ-
ismal symbiosis). This is not an approach against ge-
netics or big data. Rather, it demands a broadening of 
the scientific portfolio, so that other perspectives are 
also included in biological funding and as appropriate 
biological explanations. It argues that scientific data 
—especially those of phenotypic plasticity and devel-
opmental symbiosis--reveal that the physical organism 
is critically important, and that environmental context 
plays a large role in gene expression. This would make 
“personalized medicine” a very improbable goal.
Developmental plasticity is the normal ability of 
a single genome to produce different phenotypes de-
pending on the environment. This has been documented 
throughout the animal and plant kingdoms (see Gilbert 
and Epel, 2015; Sultan, 2015). The presence of different 
temperatures can alter the sex of turtles and fish and the 
pigments of butterflies; the presence of predators in the 
environment can change the phenotypes of many ver-
tebrates and invertebrates to give them protective struc-
tures (often at the expense of reproductive organs), and 
different diets in utero can yield different phenotypes 
in mice and rats. Indeed, the ratios of enzymes that me-
tabolize glucose and fats in mature mice are altered by 
the diet that the mouse experienced in utero (Lillycrop 
et al, 2005; Lillycrop and Burde, 2015). Genetically iden-
tical rats can have different behaviors, since maternal 
grooming can initiate a hormonal cascade that demeth-
ylates certain genes whose products (such as the glu-
cocorticoid receptors) promote and constrain certain 
behaviors (Weaver et al, 2004). 
Developmental plasticity also enables an organism 
to metabolize drugs differently. When wood frog tad-
poles are exposed to certain herbicides, the herbicides 
seem to be harmless to the animals. However, when the 
tadpoles are exposed to the same concentration of her-
bicides, but in the presence of predators or competitors, 
they die (Relyea and Mills, 2001; Jones et al, 2011). The 
metabolism of the herbicide depends on the environ-
mental stresses given to the tadpoles. Similarly, humans 
are thought to metabolize drugs differently under dif-
ferent stress conditions (Konstandi et al, 2014; Rabasa 
and Dickson, 2016). Stress-induced glucocorticoids ac-
tivate the adrenergic receptors and play a major role in 
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regulating the enzymes that metabolize drugs. So in 
addition to genes, long-term plasticity and short- term 
stressors also play roles in drug metabolism. These and 
other epigenetic effects (such as those induced by aging 
or lifestyle) mean that even though one has particular 
genetic alleles, whether they are functional or not de-
pends upon chance and environmental contexts. In-
deed, cancer cells are often found to have unbalanced 
epigenomes (Feinberg, 2018). This does not bode well 
for personized medicine based on one’s genome. 
Symbioses are also universal, and they also play ma-
jor roles in drug metabolism. In addition to the 22,000 
genes we receive from our human parents, we receive 
about 8,000,000 different genes from the bacteria that 
reside in and on our body. We have as many bacteria as 
we have diploid cells, and it is thought that the micro-
biome is as active as our liver. As much a thirty percent 
of the metabolites in our blood are direct or indirect 
products of our symbiotic bacteria (McFall-Ngai, 2013). 
Differences in bacteria have been shown to effect the 
ways individual patients metabolize drugs for cardiac 
arrhythmias, cancers, psychotic conditions, diabetes, 
and other medical conditions (Patterson et al 2014; Go-
palakrishnan et al, 2018). Identical twins discordant for 
kwashiorkor were found to harbor different bacteria, 
and the sick twin underwent remission when his bac-
teria were altered by dietary means (Smith et al, 2013). 
Differences in fish bacteria are reflected in diabetic con-
ditions, as certain bacteria are necessary for the expan-
sion of pancreatic beta cells (Hill et al, 2016).
This, too, bodes poorly for personalized medicine. 
Differences in the drug metabolism can be due to sev-
eral genomes, not merely the one we inherit from our 
parents’ gametes (Spanogiannopoulos et al, 2016; Turn-
baugh, 2018). Indeed, the environment can alter the 
symbionts, since each time we eat, we change the pop-
ulations of bacteria in our gut. If environments are so 
important, the very notion of genome-based predicta-
bility is fundamentally undermined. Personalized med-
icine would have to know a patient’s bacterial genomes, 
stress responses, and how these were integrated at the 
time the drug is given.
Ecological developmental biology takes biology out 
of the laboratory and into the real world, melding bio-
logical data with political and social concerns. This is 
especially seen in research in cancer and endocrine dis-
ruptors. In cancer research, the genome projects have 
so far failed to find the common alleles for common tu-
mors. Indeed, there is much evidence suggesting that 
tumors originate through a variety of mechanisms that 
disrupt communication between the tissues of the body. 
This has given rise to the Tissue Organization Field 
Theory, an important alternative to the genomic somat-
ic mutation theory (Sonnenschein and Soto 1999; 2017). 
TOFT claims that the evidence supports a tissue-level, 
rather than cellular level, model for the origins of tum-
ors, that most cancer-causing agents do not cause mu-
tations, and that change and motion, rather than stasis, 
is the default case of cells. Thus, knowledge of the ge-
nome won’t help prevent cancers as much as removing 
oncogenic chemicals (such as the endocrine disruptor 
bisphenol-A, which, like most cancer-forming agents, 
is not a mutagen) from the environment. 
In TOFT and in related endocrine disruptor research, 
the biochemical pathways involved in hormone synthe-
sis and the repression of cell division are linked with the 
ecological pathways concerning their use and the polit-
ical pathways concerning their manufacture and licens-
ing. For example, when Tyrone Hayes (2005) represents 
the pathway of endocrine disruption from the herbicide 
atrazine, his illustration includes the biochemical, ge-
netic, political, and environmental causes. The biochem-
ical reaction converting testosterone into estrogen is in 
the center of the figure. The geopolitical and economic 
concerns are upstream in the figure, leading to the pro-
duction of atrazine, which stimulates the activity of the 
aromatase enzyme that converts testosterone into estro-
gen. Below the chemical reaction are the endocrinologi-
cal results of “demasculinization” and “femininization”, 
both of which lead to the physiological and behavioral 
phenotype: “decreased reproductive success”. From 
here, Hayes puts arrows to the two evolutionary conse-
quences: “Extinction” and “Adaptation”.
Alternative sciences, such as ecological developmen-
tal biology and the TOFT approach to cancer research 
may become critically important, especially if the per-
sonalized medicine promised by genomics fails to oc-
cur. While GWAS studies have found only a few rare 
diseases associated with rare markers, it has not ful-
filled its promise to find common genetic variants that 
cause common diseases and conditions such as cardi-
ovascular disease (CVD), obesity, Parkinson’s disease, 
and intelligence. Indeed, recent studies suggest that the 
genetic variants found by GWAS are swamped by envi-
ronmental factors. For instance, Pazoki and colleagues 
(2018) have shown that despite the genetic risk for 
high blood pressure and CVD predicted by 314 GWAS 
variants, lifestyle quality was associated with CDV at 
p<10-320. The genetic variation was seen to cause less than 
3% of the variation in blood pressure. To prevent CDV, 
the authors recommend changes in lifestyle, and they 
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are concerned with the possible negative consequences 
of disclosing genetic risks about blood pressure. Similar-
ly, while the headline (Zimmer, 2017) stated “In ‘enor-
mous success,’ scientists tied 52 genes to human intel-
ligence,” further reading showed that these 52 allelic 
differences collectively accounted for less than 5% of the 
variance among the people3(Snieckers et al, 2017).
The GWAS program is also failing in cancer research. 
Common cancers were not seen to be produced by or 
associated with common genetic variations. Indeed, 
rather than finding common variants for common can-
cers, the Cancer Genome Atlas project found nearly 3000 
mutations appear to be associated with tumors (Baily et 
al, 2018; Feinberg 2018). Jamshidi et al (2017) found no 
difference in the mutational burden of “cancer-associat-
ed genes” when comparing malignant prostate cancers 
to adjacent regions that were normal or merely suspi-
cious. Harold Varmus, Director of the National Cancer 
Institute, remarked nearly a decade ago (Wade, 2010), 
“Genomics is a way to do science, not medicine,” and 
Robert Weinberg (2014), who brought the somatic mu-
tation theory of cancer to such prominence, now admits 
that most cancers are not caused by mutation. 
So, there is evidence that the claim that knowing 
one’s genome will enable one to get the best set of drugs 
or the best preventative care may be a fantasy. More-
over there is biological evidence that the environment 
has agency in normal and pathological conditions, 
sometimes interacting with and sometimes trumping 
the genome. Yet, our news broadcasts are replete with 
assumptions that genes, alone, are responsible for our 
health or sickness4. And the US government is willing 
3 It must be recalled that all GWAS can give us are correlations, the 
weakest type of inference, without evidence of causation. Thus, 
Big Data will give spurious correlations, such as the divorce rate 
in Maine correlating (99.26%) with the per capita consumption 
of margarine (Vigen 2015). Indeed, the number of nesting storks 
observed in Germany from 1965 to 1980 correlates quite well with 
the number of live births there during those same years (Sies 1988), 
an association which, if causal, would undermine the foundations 
of both genetics and embryology. The microchimerism now seen 
to pervade our body (Lodato et al 2018) makes such spurious 
associations very probable. Other problems with GWAS include 
what to do with the data. One possible GWAS association, 
that between an allele of the NFKB1 gene and asthma in black 
children, provides a stark ethical quandary. If asthma is caused 
by the combination of a particular allele and bad air quality, does 
one develop a drug to alleviate the disease (albuterol does not 
appear to work well on people with this allele of NFKB1) that 
will be at the expense of the families, or does one try to alleviate 
the bad air quality? Extending this model beyond poor urban 
blacks, will each of us be expected to take personalized medicines 
to allow us to survive in an otherwise toxic environment, i.e., 
Roundup for humans?
4 As I write this, my newsfeed shows an article from Business 
to shunt billions of dollars from normal biology and 
health care programs into the very unlikely program 
that genomics will solve our health problems and give 
us a more just society.
What could explain this?
3. Fetishism
Possibly, fetishism. Let’s approach personalized 
medicine as the fetishism of the genome, empowered 
by industry. Fetishism can be defined as the worship 
of some object or idea for its alleged magical powers or 
as the excessive attachment or attention given to some 
object or idea. In this case, the object of such veneration 
is the genome. The three-way intermeshing of science, 
religion, and economics has yielded a strange outcome, 
where the hereditary material has been honed to be a 
financial tool, and traditional antagonisms, such as that 
between biology and religion, are transcended. 
The fetishization of genes goes way back to its or-
igins in Morgan’s laboratory (see Gilbert, 1998). The 
early geneticists used so much religious rhetoric in 
promoting their new science that historian R. E. Kohler 
(1994) noted that, “the Morgan crowd did sometimes 
sound like prophets of a new religion”. Morgan, es-
pecially, liked to say that genetics had superseded ex-
perimental embryology, which “ran for a while after 
false gods that landed it in a maze of metaphysical 
subtleties” (Morgan, 1932). At the dawn of the molec-
ular age, Jack Cohen (1979) railed against the ‘DNA-
is-God-and-RNA-is-his-prophet molecular biologists.” 
But as the human genome project took over the field 
of genetics, all manner of rhetoric sought to give the 
life-giving power of the Deity to the “master mole-
cule” of life (Keller, 1992). Dorothy Nelkin and Susan 
Lindee’s (1995) The DNA Mystique shows that DNA has 
become the secular analogue of “soul.” It has become 
our “essence,” the basis of our physical and behavio-
ral phenotypes. When an advertisement says that “the 
sauna is in the DNA of every Finn,” or that the mid-
sized Hummer has the “same DNA” as the regular 
model, we know that “DNA” has replaced the word 
“soul.” Similarly, when the advertisement for Ances-
try.com tells you that their analysis of your DNA will 
be “revealing what it is that makes you, you,” they are 
selling an ideology that your essence is your genome5. 
Insider (Brueck 2018), declaring matter-of-factly that “All cancer 
is a result of DNA damage or genetic mutations in our DNA.” 
Meanwhile, another article (Craig 2018) calls for turning more 
biologists in “bioinformaticians”.
5 This genomic fetishism also puts a premium on having a 
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But the leaders of such rhetoric that instilled God-
like agency to the genome are the two archrivals of the 
contemporary science-religion conflict, Francis S. Col-
lins and Richard Dawkins. Richard Dawkins has been 
the great popularizer of genetic determinism for the 
general public. His book The Selfish Gene has been voted 
the most inspiring British science book of all time by the 
Royal Society of London (2017). This is the book where-
in Dawkins claims, “We are survival machines-robot ve-
hicles blindly programmed to preserve the selfish mole-
cules known as genes”. He can be remarkably poetic. In 
The Blind Watchmaker (1986), he writes:
It is raining DNA outside. On the banks of the Oxford 
canal at the bottom of my garden is a large willow 
tree and it is pumping downy seeds into the air.... not 
just any DNA but DNA whose coded characteristics 
spell out specific instructions for building willow 
trees that will shed a new generation of downy seeds. 
These fluffy specks are literally spreading instructions 
for making themselves. They are there because their 
ancestors succeeded in doing the same. It’s raining 
instructions out there. It’s raining programmes; it’s 
raining tree-growing, fluff-spreading algorithms. This 
is not a metaphor, it is the plain truth. It couldn’t be 
plainer if it were raining floppy discs.
The genetic program is, of course, a metaphor. And 
it is about as up-to-date as floppy discs. But just as 
importantly, as alluded to by its title, The Blind Watch-
maker, Dawkins has become the public atheist of the 
English-speaking world. He is the scientist against re-
ligion, the one who is certain that God does not exist. 
Evolution has taken over from God the ability to gen-
erate life, and at the center of evolution are the algo-
rithms of the genome.
For Francis S. Collins, the head of the Human Ge-
nome Project and the current Director of the Nation-
al Institutes of Health, the human genome is the sig-
nature of God, “God’s Instruction Book”. Indeed, he 
writes that his decision to become director of the Hu-
man Genome Project was that of a response to a calling 
(Collins 2006, p. 119). 
biologically related baby. “Who are you?” becomes less a matter 
of how you were raised and what opportunities or crises you had, 
than what your human genome is. Moreover, identity politics 
become reified, as one finds out that you are, for instance 25% 
German and 25% Sardinian. Can someone be 100% German? 
What does this mean? “Sardinian” is an actual category for some 
of the commercial companies, despite the fact that Sardinia is at 
the border between Europe and Africa, and has been ruled by 
Phoenician, Roman, Visigoth, Byzantine, and Islamic cultures. To 
be 25% Sardinian must be similar to being 25% New Yorker.
As a believer in God, was this one of those moments 
where I was somehow being called to take a larger role 
in a project that would have profound consequences 
for our understanding of ourselves? Here was a chance 
to read the language of God, to determine the intimate 
details of how humans had come to be. 
Collins spends a chapter of his The Language of God 
defending his theistic evolution against the atheism of 
Dawkins, with whom he’s publically debated. 
 Collins’ theistic evolution is the striving of the nat-
ural world towards its telos—humans, the animals 
that can understand God and God’s creation. No other 
genomes are mentioned. Collins’ evolutionary tale is 
an exclusionary and exclusivist one. Humans are the 
pinnacle of evolved creation. No other animal or plant 
needs to be considered. Collins’ God wrote his signa-
ture into the human genome, and his biology concerns 
no other animal. Collins (and for that matter, his finan-
cial backers, such as Bill and Melinda Gates), are inter-
ested in farms, not ecosystems (see Gates 2018). The 
only genomes that matter are those involved directly 
with human welfare. Several anthropologists have re-
cently warned (Haraway et al, 2015) we are entering a 
Plantationocene Epoch, where the world is merely a 
farm for human exploitation. At a time when the plan-
et’s ecosystem needs our help the most, the most im-
portant person in prioritizing the funds of life sciences 
in the United States is a God-fearing human exclusivist. 
Another inconvenient truth. 
The concept of fetishism does some heavy work. 
First, as mentioned above, it unites religious and anti-re-
ligious rivals. The pious Christian NIH director Fran-
cis Collins and his atheist opponent, Richard Dawkins, 
are now fighting on the same side—for the genome. 
They both can be seen as idolaters worshipping the 
same totem. Both worship the genome as the Demi-
urge of creation. If one wishes icons, look to the cover 
of The Language of God, to see the double helix done in 
stained glass. 
Second, there is epistemic ambivalence that allows 
one to believe in the fetish while knowing full well that 
it is not the truth. This ambivalence—the fetish-wor-
shipper knows the fetish is man-made, even as he 
gives it supernatural power-- is characteristic of fetish-
ism (Latour, 2010). Geneticists know that the genome 
is a surrogate (or at best, a simplification) of multiple 
networks of social and scientific enterprises (Hara-
way, 1997). We know that most cancers are not genetic 
(Sonnenschein and Soto 2017b) and that environmental 
changes can be effective means to preventing cancers 
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and many non-infectious diseases. We know that devel-
opmental plasticity and symbionts change the way we 
metabolize our drugs. But the genome projects contin-
uously add epicycles to their genomic theories. The ge-
nomes are given unique agency, denying and disavow-
ing both the interactions of phenotype production and 
the cultural interactions that brought the genome into 
material-semiotic existence (Haraway 1997, p. 143). As 
Richard Lewontin (1992, p. 33) said, “First, DNA is not 
self-reproducing, second, it makes nothing, and third, 
organisms are not determined by it.”
Third, according to H. K. Bhabha (1994), the fetish 
“gives access to an ‘identity’ which is predicated as 
much on mastery and pleasure as it is on anxiety and 
defense, for it is a form of multiple and contradictory 
belief in its recognition of difference and disavowal of 
it.” This observation is paramount; for the genome is 
seen by its worshippers as both (1) the handiwork of 
God, stunning evidence of His creative power, and at 
the same time, (2) the source of humanity’s misery and 
disease. Both holy similarity and debilitating allelic dif-
ferences are critical for the argument for personalized 
medicine. The fetish encourages and is sustained by 
this ambiguity. 
Fourth, there is commodity fetishism, which de-
mands the abstraction of the entity coupled with its 
later interpretation of worth. The abstractive flattening 
involves the compression of many rich dimensions of 
living organisms into algorithmic computations. The 
science of life has become the science of genes, and 
the science of genes has become bioinformatics, which 
takes its place in the executive suite of capitalism’s 
“economics of information.” Biology is no longer the 
study of living organisms, but a set of wagers concern-
ing the outcomes of sequence recombinations. Stengers 
calls it a “capture” of biology. This process of making 
the fetish (according to Marx, cited in Keenan 1993, 
p.130) de-animates entities and then re-animates them 
without presuming they had any life prior to the ab-
straction. “Value,” writes Marx (167/88), “does not have 
its description branded on its forehead; rather it trans-
forms every product of labor into a social hieroglyphic. 
Later on, men try to decipher the hieroglyphic.” The 
labor of many people and expensive machines have 
turned humans into data, and the value of this data will 
be determined by the social interactions among poten-
tial consumers. Donna Haraway wrote (1997, p. 135), 
“Ask any biodiversity lawyer whether genes are sourc-
es of ‘value’ these days, and the structure of commodity 
fetishism will come clear.” Twenty years later, a recent 
reviewer of Reardon’s book (Isasi, 2017) maintains, 
“The human genome has an ineffable value.” Q.E.D.
 Those who possess and control the data demand 
that it be considered a most valuable possession. And 
this worth can be evidenced by the amount of labor put 
into extracting it and the perception that it is something 
that generates wealth. (Indeed, the dominant metaphor 
has been that data is a precious stone that is “mined.” 
There is no intrinsic worth to a ruby or sapphire ex-
cept that which our interactions have placed on it. And 
it “means” little until it is properly cut. Similarly, the 
DNA sequence is just a series of nucleotides until it gets 
placed in a setting that gives it worth.) This means that 
there has to be concerted effort by those possessing the 
data to have society agree that this information is, in-
deed, worth having. Health is a value worth having, 
and Collins knows the power of his budget to make 
health equal genomics. At the recent annual meeting of 
the American Society of Human Genetics, Collins (2017) 
is reported to have told the assembled researchers,
“Researchers may not always like to share their data, 
and getting them to behave in certain ways can seem 
like herding cats“, Collins said, “but I have a big bag of 
cat food, which is the NIH budget”.
Herding cats is easy when you hold the power of 
life or death over their projects. Richard Goldschmidt 
(1949) predicted this in his prophetic paper 70 years 
ago, and it is worth reading in the footnote6.
6 From Goldschmidt (1949): But now a man does not work on some 
subject or problem. He has a “project.” A plan has been laid out, 
even worked out in all detail, a staff has been brought together 
and each one has been assigned his duty. An organization has 
approved the plan and furnished the funds; in return it expects 
progress reports, visible and quick results, and no deviation from 
the plan agreed upon. Everybody is happy to have a “project,” 
and only Minerva covers her face and sends the owl away to catch 
mice. I realize certainly that there are types of work which should 
be handled as organized “projects.” If you want to prepare 200 
stereoisomers of some organic compound and test their action 
as insecticides, a project is in order. If you want to eradicate a 
certain mosquito in a certain place, go and organize it. But how 
a major discovery or idea can come from a project I am unable to 
understand. This, however, is not what I want to discuss. I want, 
rather, to point to the danger to the freedom of science which lurks 
behind this way of making science. The danger will come from 
the men who are attracted to such a type of scientific big business. 
The thinker, the blaster of new paths, the keen observer, the man 
of intuition whose thinking is ahead of his time, will not flock to 
the big Government-financed and -sponsored projects. Sooner or 
later leadership will fall to the university politician, the promoter, 
the men who make the headlines--headlines not in the history of 
discovery but in the press. Second-raters will attain the power that 
goes with the big funds, and then the moment of danger arrives. 
They will favor what they like and understand, suppress what is 
beyond their vision. Being not too intelligent, they will fall prey 
to the flatterer, and will always go along with the latest scientific 
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4. Concluding remarks
The projects that replace creative science in Gold-
schmidt’s dire prophecy are those now detailed by 
Reardon. The latter, unplanned, science mentioned 
at the end of Goldschmidt’s diatribe is the “other sci-
ence” that Stengers alludes to. It is not a return to a 
past that never was. Rather, it is an amalgamation of 
all that science, philosophy, sociology, and art can 
bring together. It is a mindful science, where the mind 
is now able to access areas of philosophy, sociology, 
and art that were previously “unthinkable”. It seeks 
a science that does not go alongside the humanities 
and social sciences, and that does not conquer the hu-
manities and social sciences; but a science travels with 
them, making new chimeras of thought that will pro-
mote and constrain various types of scientific research 
programs. It looks forward to a fully renewed biolog-
ical science that will take on the questions of promot-
ing thriving ecosystems rather than attending solely 
to the more immediate questions of human health and 
longevity. 
In addition to the Allegory of the Cave, another fa-
mous scientific trope is the Displacement of Humans: 
Copernicus showed that the earth is not the center of 
the universe, Darwin showed that man is not the center 
of life, and Freud showed that the conscious brain is not 
fashion or even the doubtful schemes of fanatics or reactionaries, 
and certainly always with well-entrenched schools. They will 
easily find the ear of the politicians who run the funds, for both talk 
the same language. At this point the setting is ready for a Lysenko 
type. Though our political system will not give him a chance to act 
as savagely as is possible in Russia, he could do enormous damage 
to the progress of science and the freedom of research if not 
checked in time. This sounds very pessimistic, but human nature is 
the same everywhere, fanatical activists are available everywhere 
if not kept in check, and men who believe in “politics as usual” 
are not only more numerous than men of original ideas but are 
also more selfish and ruthless. Thus, I believe that the increasing 
financial support of research, especially by government and 
political agencies, tending to flow into the channels of organized 
research, is fraught with the danger of bossism in science, with 
the danger of subsidizing mediocrity, and in the end with a threat 
to the freedom of science and its teaching. This is not to say that I 
am opposed to government funds’ being set aside for fundamental 
research. This is a need of our time, a necessity. But precautions 
should be taken and a watchful eye should be kept to prevent such 
funds from working to the detriment of real science. It is the young 
generation, who will profit from the incoming funds, who should 
also be alerted against the danger that politicians, both those 
within and those outside the universities, will take over science. 
The young researcher must insist upon the right to think for 
himself, to plan for himself, to make his own mistakes, and to be 
happy over an unplanned, unforeseen discovery. Real progress in 
science has always been made and will always be made by the free 
mind, left to its own working under a system where science is free.
the center of thought. However, if Stengers and Rear-
don are correct, we’ve placed humans and the human 
genome right back into the center of our universe. In-
deed, “the human genome” is becoming a sociotechni-
cal system, something (like coal or guns) that constructs 
the social and political order not only by its technical 
properties, but also by the institutions that emerge to 
organize it, make it useful, or realize its social poten-
tial (Lindee, personal communication). This worldview 
has impoverished the biological sciences and may be 
severely impairing our medical sciences. 
These books are also calls to arms, beseeching biol-
ogists to “take back” biology from informational bio-
technology, and to study and appreciate organisms, 
their interactions, and their messy interpenetrations. 
Others have also argued this point. Ken Weiss (2017) 
for instance, claims that Big Data projects are locking 
up far too much of America’s funding for biomedical 
research, and he suggests that we should pursue inten-
sive research in curing such obvious genetic diseases 
as cystic fibrosis and Huntington’s disease before we 
start looking at autism, schizophrenia, or those health 
problems where lifestyle changes are already known to 
work. But the problem, he writes, is “that the reality of 
improving the yield of publically sponsored science is 
about the money, not the science.”
 And this may be a problem that bodes poorly not 
only for biology and for personalized medicine, but 
also for the global economy and the roles universities 
play in the world. Mirowski (2012) has characterized 
the modern commercialization of biology as a “passel 
of Ponzi schemes.” He notes that intent to defraud is 
not necessary for an investment strategy to turn into a 
Ponzi scheme. It can emerge quite naturally from inves-
tors desiring to make large profits when a product is 
being promised, such that dividends are paid to early 
investors from the money deposited by later investors. 
Many major research universities have invested whole-
heartedly in these schemes, and as Mirowski (p. 288) 
sadly notes, “there is no governmental equivalent of the 
Federal Reserve to intervene in order to rescue univer-
sities deemed too big to fail, or too significant in the cul-
tural patrimony to abandon”. In the conclusion of their 
article on “saving science,” Bizzarri and colleagues 
(2017) quote Carl Woese’s dictum that “a society that 
permits biology to become an engineering discipline 
...is a danger to itself.” These are important books for 
realizing what may be happening our worldview of sci-
ence, nature, and technology.
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